“Synthesis and Characterization of YYGSR-NH2 as a Chemical Starting Poin for Thyroid Theranostic Radiopharmaceutical Development”, JFM, vol. 9, no. 1, pp. 830–841, Oct. 2026, doi: 10.35451/jfm.v9i1.3856.